OTC Medicines Corner

SORT BY:     Most Recent      Most Viewed
  • April 1, 2007

    For cardioprotection, doses of aspirin higher than 75 to 81 mg daily are not supported by available evidence, based on findings of a trial reported recently in JAMA. Higher doses are...

  • February 1, 2007

    The abuse of the OTC ingredient dextromethorphan has been growing steadily for several years, particularly in the adolescent age group. Perceived safety, ease of availability, and desired...

  • December 1, 2006

    FDA has proposed amending the labeling regulations for nonprescription Internal Analgesic, Antipyretic, and Antirheumatic (IAAA) drug products to emphasize more strongly the potential for...

  • October 1, 2006

    The need for a law creating a behind-the-counter category of products in U.S. pharmacies is a central discussion point in the ongoing debate over the wisdom of making low-dose statins available...

  • August 1, 2006

    FDA has approved Plan B, the levonorgestrel emergency contraceptive marketed in the United States by Barr Laboratories’ subsidiary Duramed, for over-thecounter sales to women aged 18 years and...